Zebra Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,625
Closed -$380K 80
2022
Q3
$380K Buy
28,625
+2,273
+9% +$39.2K 1.45% 29
2022
Q2
$504K Buy
26,352
+3,279
+14% +$62.1K 1.48% 24
2022
Q1
$460K Sell
23,073
-3,143
-12% -$63.5K 1.06% 29
2021
Q4
$535K Sell
26,216
-9,665
-27% -$206K 0.86% 37
2021
Q3
$773K Sell
35,881
-14,158
-28% -$341K 0.94% 31
2021
Q2
$1.45M Sell
50,039
-5,403
-10% -$146K 1.69% 7
2021
Q1
$1.35M Buy
+55,442
New +$1.25M 1.49% 11
2020
Q3
Sell
-15,462
Closed -$406K 249
2020
Q2
$406K Buy
15,462
+1,522
+11% +$37.8K 0.59% 53
2020
Q1
$337K Sell
13,940
-999
-7% -$24.4K 0.54% 65
2019
Q4
$371K Buy
14,939
+1,232
+9% +$28.6K 0.33% 123
2019
Q3
$292K Buy
13,707
+4,731
+53% +$130K 0.32% 122
2019
Q2
$285K Buy
8,976
+1,917
+27% +$60.1K 0.15% 320
2019
Q1
$233K Buy
7,059
+604
+9% +$18.8K 0.12% 347
2018
Q4
$208K Sell
6,455
-197
-3% -$7.43K 0.13% 317
2018
Q3
$285K Buy
6,652
+568
+9% +$26.8K 0.13% 308
2018
Q2
$280K Sell
6,084
-871
-13% -$38.6K 0.12% 289
2018
Q1
$276K Buy
6,955
+973
+16% +$36K 0.1% 284
2017
Q4
$200K Buy
+5,982
New +$212K 0.07% 304

Other funds holding PAHC

Zebra Capital Management's PAHC Position: Q4 2022 in Review

Zebra Capital Management sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 28,625 shares — an estimated $380K sold.

Zebra Capital Management first reported a position in PAHC in Q4 2017 and held it in 18 quarters. The position peaked at $1.45M in Q2 2021. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Zebra Capital Management reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Zebra Capital Management sold 28,625 Phibro Animal Health shares in Q4 2022, an estimated $380K.
  • Zebra Capital Management first reported a position in Phibro Animal Health in Q4 2017 and held it in 18 quarters.
  • Zebra Capital Management's Phibro Animal Health position peaked at $1.45M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Zebra Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.